Data / Form D filings / Meryx Inc.
Meryx Inc.: Form D filings
Meryx Inc., a biotechnology company in Chapel Hill, NC, filed 4 Form D notices with the SEC between 2014 and 2015. The latest, on June 30, 2015, reports $2.5 million sold of a $2.5 million offering to 9 investors.
Find out what Meryx Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1414 Raleigh Road, Suite 445, Chapel Hill, NC, 27517
- Phone
- (919) 985-7821
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2013
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1606031
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 30, 2015 | New notice | $2,500,000 | $2,500,000 | $0 | 9 | Jun 23, 2015 | sec.gov |
| Dec 29, 2014 | New notice | $1,544,999 | $1,544,999 | $0 | 2 | Dec 18, 2014 | sec.gov |
| Apr 28, 2014 | Amendment | $3,100,172 | $3,100,172 | $0 | 3 | Apr 14, 2014 | sec.gov |
| Apr 28, 2014 | New notice | $3,100,172 | $3,100,172 | $0 | 3 | Apr 14, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Douglas K. Graham | Director | |
| Fred K. Eshelman | Director | |
| Seth K. Rudnick | Director | |
| Sailash K. Patel | Executive Officer | |
| Stephen V. Frye | Director | |
| H. Shelton Earp | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Jun 29, 2015 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Meryx Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.